Clinical Trial Update: Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating whether hydroxychloroquine can decrease immune activation in asymptomatic HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Medical Research Council | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN